Immunohistochemical staining revealed a significant reduction in the number of Arg-1+ cells ( P < 0.05) in the ACT001 treatment group, and the number of iNOS+ cells showed a decreasing trend ( Figure 2C ).
← all excerpts
Anticancer Effects of ACT001 via NF-κB Suppression in Murine Triple-Negative Breast Cancer Cell Line 4T1.
1
—
—